Skip to content
Biodatica
Start free

Investigator

Scott Alper

NATIONAL JEWISH HEALTH · funded by NCI, NIAID

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$958k

Summed across those awards.

First award
Mar 11, 2021

Latest Apr 1, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R21

    MDS-associated U2AF1 mutations induce natural killer cell dysfunction

    $435k

    Apr 1, 2026NCINATIONAL JEWISH HEALTHNIH RePORTER · 11302610 (opens the source filing in a new tab)

  2. R01

    MDS-Associated Spliceosome Mutations Regulate Host Defense

    $523k

    Mar 11, 2021NIAIDNATIONAL JEWISH HEALTHNIH RePORTER · 11040345 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources